Grant Support
1H79TI018710-01 (Walley) 9/30/07-09/29/2012
SAMHSA
The objective of this grant is to expand and enhance capacity for treatment of alcohol and drug dependence among HIV-infected and HIV-uninfected individuals in conjunction with comprehensive HIV/AIDS treatment and prevention services.
R01 AA016059 (Samet) 9/30/06-8/31/11
NIAAA
Maximizing Opportunity – HIV Prevention in Hospitalized Russian Drinkers
The objective of this grant is to test in a randomized controlled trial the effectiveness of a modified US HIV secondary prevention program, Healthy Relationships Intervention in risky Russian drinkers.
R25-DA13582 (Samet) 5/01/01-4/30/11
NIDA
Clinical Addiction Research and Education (CARE) Program
The major aims of this grant are to develop generalist physician drug abuse researchers, train chief resident in generalist physician disciplines about addiction to facilitate their teaching of physicians in training, and develop an on-line drug abuse literature review newsletter.
R21 DA025435 (Samet) 9/01/08-8/31/09
NIDA
Clinical Impact of Drug Use in HIV-Infected Persons: A Pilot Study
The goal of this pilot study, Drug Use IMPACT (Investigating and Measuring Progression to AIDS in a Cohort Trial), is to begin to investigate the relationship between drug abuse and HIV disease progression by utilizing a current cohort of HIV-infected adults in Russia.
R01-DA019841 (Cotton) 7/01/05-6/30/09
NIDA
Natural History of Hepatitis C Infection in HIV Disease
The goal of this study is to identify strategies to prevent the adverse outcomes associated with HIV and HCV co-infection among IDUs. The study will assess the independent effects of HIV infection, race/ethnicity, CD4 count, HIV viral load, and ART on clinical progression of liver disease and liver related mortality in HIV/HCV co-infected IDUs. It will also examine the relationship between serologic markers of hepatic fibrosis and clinical progression of liver disease.